{"title":"1例帕金森病患者持续皮下输注foslevodopa/foscarbidopa后睡眠状态改善。","authors":"Hirotaka Sakuramoto, Hiroaki Fujita, Keitaro Ogaki, Keisuke Suzuki","doi":"10.1016/j.prdoa.2024.100292","DOIUrl":null,"url":null,"abstract":"<div><div>Continuous subcutaneous infusion of foslevodopa/foscarbidopa (LDP/CDP) may be effective in improving daytime symptoms in patients with Parkinson’s disease (PD). We report on a PD patient for whom LDP/CDP treatment improved motor symptoms, sleep disturbances and sleep architecture as measured by the mobile two-channel electroencephalography/electrooculography recording system.</div></div>","PeriodicalId":33691,"journal":{"name":"Clinical Parkinsonism Related Disorders","volume":"11 ","pages":"Article 100292"},"PeriodicalIF":1.8000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11664175/pdf/","citationCount":"0","resultStr":"{\"title\":\"A patient with Parkinson’s disease whose sleep status improved after the introduction of continuous subcutaneous foslevodopa/foscarbidopa infusion\",\"authors\":\"Hirotaka Sakuramoto, Hiroaki Fujita, Keitaro Ogaki, Keisuke Suzuki\",\"doi\":\"10.1016/j.prdoa.2024.100292\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Continuous subcutaneous infusion of foslevodopa/foscarbidopa (LDP/CDP) may be effective in improving daytime symptoms in patients with Parkinson’s disease (PD). We report on a PD patient for whom LDP/CDP treatment improved motor symptoms, sleep disturbances and sleep architecture as measured by the mobile two-channel electroencephalography/electrooculography recording system.</div></div>\",\"PeriodicalId\":33691,\"journal\":{\"name\":\"Clinical Parkinsonism Related Disorders\",\"volume\":\"11 \",\"pages\":\"Article 100292\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11664175/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Parkinsonism Related Disorders\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S259011252400063X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Parkinsonism Related Disorders","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S259011252400063X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
A patient with Parkinson’s disease whose sleep status improved after the introduction of continuous subcutaneous foslevodopa/foscarbidopa infusion
Continuous subcutaneous infusion of foslevodopa/foscarbidopa (LDP/CDP) may be effective in improving daytime symptoms in patients with Parkinson’s disease (PD). We report on a PD patient for whom LDP/CDP treatment improved motor symptoms, sleep disturbances and sleep architecture as measured by the mobile two-channel electroencephalography/electrooculography recording system.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
